Aktie A2QCZA YEW BIO-PHARM GROUP, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Yew Bio-Pharm Group, Inc. Other OTC

Aktien

A2QCZA

US98584C1018

YEWB

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
Yew Bio-Pharm Group, Inc. Announces Yongchun Shi and Mr. Xiefeng Liu Resigned as the Independent Director
YEW BIO-PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Yew Bio-Pharm Group, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
Yew Bio-Pharm Group, Inc. Announces Executive Changes
Yew Bio-Pharm Group, Inc. Announces Executive Changes
Yew Bio-Pharm Group, Inc. Announces Executive Changes
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
YEW BIO P : PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Yew Bio Pharm : Announces New Cosmetic Subsidiary
Yew Bio-Pharm Group, Inc. Announces New Cosmetic Subsidiary
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
Yew Bio-Pharm Group, Inc. Announces Resignation of Guoshuang Tian as Director
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QCZA Aktie
  4. A2QCZA Aktie
  5. Nachrichten Yew Bio-Pharm Group, Inc.
  6. Andere Sprachen